ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enoxaparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-6L9458
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Enoxaparin Sodium Market Insights and Forecast to 2028
BUY CHAPTERS

Global Enoxaparin Sodium Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-6L9458
Report
August 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
TEVA
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Apotex
Cipla Ltd
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Huadong Medicine
Fosun Pharma (Gland Pharma)
Sandoz(Novartis)

Enoxaparin Sodium Sales Market Size

The global Enoxaparin Sodium market size was US$ 3582 million in 2024 and is forecast to a readjusted size of US$ 5762 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.

Enoxaparin Sodium Sales Market

Enoxaparin Sodium Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Enoxaparin Sodium market competitiveness, regional economic performance, and supply chain configurations.
Enoxaparin sodium is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
The core global manufacturers of enoxaparin sodium include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi and Amphastar. The top three manufacturers account for approximately 66% of the global share. Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.
Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share. The second and third places are North America and Asia, accounting for 19% and 16% respectively.
In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share. At the same time, in terms of sales channels, hospitals and clinics are the main sales channels, accounting for 80%.
The global Enoxaparin Sodium market is strategically segmented by company, region (country), by Type, and by Sales Channel. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Sales Channel for 2020-2031.
Market Segmentation

Scope of Enoxaparin Sodium Sales Market Report

Report Metric Details
Report Name Enoxaparin Sodium Sales Market
Forecasted market size in 2031 US$ 5762 million
CAGR 7.1%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Hospital & Clinic
  • Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, Huadong Medicine, Cipla, Taj Pharma, Chengdu Baiyu Pharmaceutical, Changzhou Qianhong Bio-pharma, Beijing SL Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Enoxaparin Sodium market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 30 mg/0.3mL in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmacy in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., 20 mg/0.2mL dominance in Europe vs. 30 mg/0.3mL demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Enoxaparin Sodium Sales Market size in 2031?

Ans: The Enoxaparin Sodium Sales Market size in 2031 will be US$ 5762 million.

What is the market share of major companies in Enoxaparin Sodium Sales Market?

Ans: The top three manufacturers account for approximately 66% of the global share.

What is the Sanofi share in Enoxaparin Sodium Sales Market?

Ans: Sanofi is the world's largest manufacturer of enoxaparin sodium, with a market share of approximately 42%.

What is the Enoxaparin Sodium Sales Market share by region?

Ans: Europe is the world's largest enoxaparin sodium market, accounting for nearly 60% of the market share.

What is the Enoxaparin Sodium Sales Market share by type?

Ans: In terms of product type, 60 mg/0.6mL occupies a dominant position, accounting for 29% of the market share.

Who are the main players in the Enoxaparin Sodium Sales Market report?

Ans: The main players in the Enoxaparin Sodium Sales Market are Sanofi, Techdow (Hepalink), Teva, Nanjing King-friend, Rovi, Fresenius Kabi, Fosun Pharma(Gland Pharma), Amphastar, Sandoz (Novartis), Apotex, Huadong Medicine, Cipla, Taj Pharma, Chengdu Baiyu Pharmaceutical, Changzhou Qianhong Bio-pharma, Beijing SL Pharmaceutical

What are the Application segmentation covered in the Enoxaparin Sodium Sales Market report?

Ans: The Applications covered in the Enoxaparin Sodium Sales Market report are Hospital & Clinic, Pharmacy, Others

What are the Type segmentation covered in the Enoxaparin Sodium Sales Market report?

Ans: The Types covered in the Enoxaparin Sodium Sales Market report are 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL

1 Market Overview
1.1 Enoxaparin Sodium Product Scope
1.2 Enoxaparin Sodium by Type
1.2.1 Global Enoxaparin Sodium Sales by Type (2020 & 2024 & 2031)
1.2.2 20 mg/0.2mL
1.2.3 30 mg/0.3mL
1.2.4 40 mg/0.4mL
1.2.5 60 mg/0.6mL
1.2.6 80 mg/0.8mL
1.2.7 100 mg/1mL
1.2.8 120 mg/0.8mL
1.2.9 150 mg/1mL
1.2.10 300mg/3mL
1.3 Enoxaparin Sodium by Sales Channel
1.3.1 Global Enoxaparin Sodium Sales Comparison by Sales Channel (2020 & 2024 & 2031)
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Enoxaparin Sodium Market Estimates and Forecasts (2020-2031)
1.4.1 Global Enoxaparin Sodium Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Enoxaparin Sodium Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Enoxaparin Sodium Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Enoxaparin Sodium Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Enoxaparin Sodium Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Enoxaparin Sodium Sales Market Share by Region (2020-2025)
2.2.2 Global Enoxaparin Sodium Revenue Market Share by Region (2020-2025)
2.3 Global Enoxaparin Sodium Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Enoxaparin Sodium Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Enoxaparin Sodium Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Enoxaparin Sodium Market Size and Prospective (2020-2031)
2.4.2 Europe Enoxaparin Sodium Market Size and Prospective (2020-2031)
2.4.3 Southeast Asia Enoxaparin Sodium Market Size and Prospective (2020-2031)
2.4.4 Israel Enoxaparin Sodium Market Size and Prospective (2020-2031)
2.4.5 China Enoxaparin Sodium Market Size and Prospective (2020-2031)
2.4.6 India Enoxaparin Sodium Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Enoxaparin Sodium Historic Market Review by Type (2020-2025)
3.1.1 Global Enoxaparin Sodium Sales by Type (2020-2025)
3.1.2 Global Enoxaparin Sodium Revenue by Type (2020-2025)
3.1.3 Global Enoxaparin Sodium Price by Type (2020-2025)
3.2 Global Enoxaparin Sodium Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Enoxaparin Sodium Sales Forecast by Type (2026-2031)
3.2.2 Global Enoxaparin Sodium Revenue Forecast by Type (2026-2031)
3.2.3 Global Enoxaparin Sodium Price Forecast by Type (2026-2031)
3.3 Different Types Enoxaparin Sodium Representative Players
4 Global Market Size by Sales Channel
4.1 Global Enoxaparin Sodium Historic Market Review by Sales Channel (2020-2025)
4.1.1 Global Enoxaparin Sodium Sales by Sales Channel (2020-2025)
4.1.2 Global Enoxaparin Sodium Revenue by Sales Channel (2020-2025)
4.1.3 Global Enoxaparin Sodium Price by Sales Channel (2020-2025)
4.2 Global Enoxaparin Sodium Market Estimates and Forecasts by Sales Channel (2026-2031)
4.2.1 Global Enoxaparin Sodium Sales Forecast by Sales Channel (2026-2031)
4.2.2 Global Enoxaparin Sodium Revenue Forecast by Sales Channel (2026-2031)
4.2.3 Global Enoxaparin Sodium Price Forecast by Sales Channel (2026-2031)
4.3 New Sources of Growth in Enoxaparin Sodium Application
5 Competition Landscape by Players
5.1 Global Enoxaparin Sodium Sales by Players (2020-2025)
5.2 Global Top Enoxaparin Sodium Players by Revenue (2020-2025)
5.3 Global Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium as of 2024)
5.4 Global Enoxaparin Sodium Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Enoxaparin Sodium, Product Type & Application
5.7 Global Key Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Enoxaparin Sodium Sales by Company
6.1.1.1 North America Enoxaparin Sodium Sales by Company (2020-2025)
6.1.1.2 North America Enoxaparin Sodium Revenue by Company (2020-2025)
6.1.2 North America Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.1.3 North America Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.1.4 North America Enoxaparin Sodium Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Enoxaparin Sodium Sales by Company
6.2.1.1 Europe Enoxaparin Sodium Sales by Company (2020-2025)
6.2.1.2 Europe Enoxaparin Sodium Revenue by Company (2020-2025)
6.2.2 Europe Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.2.3 Europe Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.2.4 Europe Enoxaparin Sodium Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.3.1 Southeast Asia Enoxaparin Sodium Sales by Company
6.3.1.1 Southeast Asia Enoxaparin Sodium Sales by Company (2020-2025)
6.3.1.2 Southeast Asia Enoxaparin Sodium Revenue by Company (2020-2025)
6.3.2 Southeast Asia Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.3.3 Southeast Asia Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.3.4 Southeast Asia Enoxaparin Sodium Major Customer
6.3.5 Southeast Asia Market Trend and Opportunities
6.4 Israel Market: Players, Segments, Downstream and Major Customers
6.4.1 Israel Enoxaparin Sodium Sales by Company
6.4.1.1 Israel Enoxaparin Sodium Sales by Company (2020-2025)
6.4.1.2 Israel Enoxaparin Sodium Revenue by Company (2020-2025)
6.4.2 Israel Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.4.3 Israel Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.4.4 Israel Enoxaparin Sodium Major Customer
6.4.5 Israel Market Trend and Opportunities
6.5 China Market: Players, Segments, Downstream and Major Customers
6.5.1 China Enoxaparin Sodium Sales by Company
6.5.1.1 China Enoxaparin Sodium Sales by Company (2020-2025)
6.5.1.2 China Enoxaparin Sodium Revenue by Company (2020-2025)
6.5.2 China Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.5.3 China Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.5.4 China Enoxaparin Sodium Major Customer
6.5.5 China Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Enoxaparin Sodium Sales by Company
6.6.1.1 India Enoxaparin Sodium Sales by Company (2020-2025)
6.6.1.2 India Enoxaparin Sodium Revenue by Company (2020-2025)
6.6.2 India Enoxaparin Sodium Sales Breakdown by Type (2020-2025)
6.6.3 India Enoxaparin Sodium Sales Breakdown by Sales Channel (2020-2025)
6.6.4 India Enoxaparin Sodium Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Sanofi Enoxaparin Sodium Products Offered
7.1.5 Sanofi Recent Development
7.2 Techdow (Hepalink)
7.2.1 Techdow (Hepalink) Company Information
7.2.2 Techdow (Hepalink) Business Overview
7.2.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Techdow (Hepalink) Enoxaparin Sodium Products Offered
7.2.5 Techdow (Hepalink) Recent Development
7.3 Teva
7.3.1 Teva Company Information
7.3.2 Teva Business Overview
7.3.3 Teva Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Teva Enoxaparin Sodium Products Offered
7.3.5 Teva Recent Development
7.4 Nanjing King-friend
7.4.1 Nanjing King-friend Company Information
7.4.2 Nanjing King-friend Business Overview
7.4.3 Nanjing King-friend Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Nanjing King-friend Enoxaparin Sodium Products Offered
7.4.5 Nanjing King-friend Recent Development
7.5 Rovi
7.5.1 Rovi Company Information
7.5.2 Rovi Business Overview
7.5.3 Rovi Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Rovi Enoxaparin Sodium Products Offered
7.5.5 Rovi Recent Development
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Information
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Fresenius Kabi Enoxaparin Sodium Products Offered
7.6.5 Fresenius Kabi Recent Development
7.7 Fosun Pharma(Gland Pharma)
7.7.1 Fosun Pharma(Gland Pharma) Company Information
7.7.2 Fosun Pharma(Gland Pharma) Business Overview
7.7.3 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Fosun Pharma(Gland Pharma) Enoxaparin Sodium Products Offered
7.7.5 Fosun Pharma(Gland Pharma) Recent Development
7.8 Amphastar
7.8.1 Amphastar Company Information
7.8.2 Amphastar Business Overview
7.8.3 Amphastar Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Amphastar Enoxaparin Sodium Products Offered
7.8.5 Amphastar Recent Development
7.9 Sandoz (Novartis)
7.9.1 Sandoz (Novartis) Company Information
7.9.2 Sandoz (Novartis) Business Overview
7.9.3 Sandoz (Novartis) Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Sandoz (Novartis) Enoxaparin Sodium Products Offered
7.9.5 Sandoz (Novartis) Recent Development
7.10 Apotex
7.10.1 Apotex Company Information
7.10.2 Apotex Business Overview
7.10.3 Apotex Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Apotex Enoxaparin Sodium Products Offered
7.10.5 Apotex Recent Development
7.11 Huadong Medicine
7.11.1 Huadong Medicine Company Information
7.11.2 Huadong Medicine Business Overview
7.11.3 Huadong Medicine Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Huadong Medicine Enoxaparin Sodium Products Offered
7.11.5 Huadong Medicine Recent Development
7.12 Cipla
7.12.1 Cipla Company Information
7.12.2 Cipla Business Overview
7.12.3 Cipla Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Cipla Enoxaparin Sodium Products Offered
7.12.5 Cipla Recent Development
7.13 Taj Pharma
7.13.1 Taj Pharma Company Information
7.13.2 Taj Pharma Business Overview
7.13.3 Taj Pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Taj Pharma Enoxaparin Sodium Products Offered
7.13.5 Taj Pharma Recent Development
7.14 Chengdu Baiyu Pharmaceutical
7.14.1 Chengdu Baiyu Pharmaceutical Company Information
7.14.2 Chengdu Baiyu Pharmaceutical Business Overview
7.14.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Products Offered
7.14.5 Chengdu Baiyu Pharmaceutical Recent Development
7.15 Changzhou Qianhong Bio-pharma
7.15.1 Changzhou Qianhong Bio-pharma Company Information
7.15.2 Changzhou Qianhong Bio-pharma Business Overview
7.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Products Offered
7.15.5 Changzhou Qianhong Bio-pharma Recent Development
7.16 Beijing SL Pharmaceutical
7.16.1 Beijing SL Pharmaceutical Company Information
7.16.2 Beijing SL Pharmaceutical Business Overview
7.16.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Beijing SL Pharmaceutical Enoxaparin Sodium Products Offered
7.16.5 Beijing SL Pharmaceutical Recent Development
8 Enoxaparin Sodium Manufacturing Cost Analysis
8.1 Enoxaparin Sodium Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Enoxaparin Sodium
8.4 Enoxaparin Sodium Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Enoxaparin Sodium Distributors List
9.3 Enoxaparin Sodium Customers
10 Enoxaparin Sodium Market Dynamics
10.1 Enoxaparin Sodium Industry Trends
10.2 Enoxaparin Sodium Market Drivers
10.3 Enoxaparin Sodium Market Challenges
10.4 Enoxaparin Sodium Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
FEATURED COMPANIES
Sanofi
TEVA
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Apotex
Cipla Ltd
Taj Pharma
Chengdu Baiyu Pharmaceutical
Changzhou Qianhong Bio-pharma
Beijing SL Pharmaceutical
Huadong Medicine
Fosun Pharma (Gland Pharma)
Sandoz(Novartis)
List of Tables
 Table 1. Global Enoxaparin Sodium Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Enoxaparin Sodium Sales (US$ Million) Comparison by Sales Channel (2020 & 2024 & 2031)
 Table 3. Global Market Enoxaparin Sodium Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Enoxaparin Sodium Sales (M Units) by Region (2020-2025)
 Table 5. Global Enoxaparin Sodium Sales Market Share by Region (2020-2025)
 Table 6. Global Enoxaparin Sodium Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Enoxaparin Sodium Revenue Share by Region (2020-2025)
 Table 8. Global Enoxaparin Sodium Sales (M Units) Forecast by Region (2026-2031)
 Table 9. Global Enoxaparin Sodium Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Enoxaparin Sodium Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Enoxaparin Sodium Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Enoxaparin Sodium Sales by Type (M Units) & (2020-2025)
 Table 13. Global Enoxaparin Sodium Sales Share by Type (2020-2025)
 Table 14. Global Enoxaparin Sodium Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Enoxaparin Sodium Price by Type (US$/Unit) & (2020-2025)
 Table 16. Global Enoxaparin Sodium Sales by Type (M Units) & (2026-2031)
 Table 17. Global Enoxaparin Sodium Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Enoxaparin Sodium Price by Type (US$/Unit) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Enoxaparin Sodium Sales by Sales Channel (M Units) & (2020-2025)
 Table 21. Global Enoxaparin Sodium Sales Share by Sales Channel (2020-2025)
 Table 22. Global Enoxaparin Sodium Revenue by Sales Channel (US$ Million) & (2020-2025)
 Table 23. Global Enoxaparin Sodium Price by Sales Channel (US$/Unit) & (2020-2025)
 Table 24. Global Enoxaparin Sodium Sales by Sales Channel (M Units) & (2026-2031)
 Table 25. Global Enoxaparin Sodium Revenue Market Share by Sales Channel (US$ Million) & (2026-2031)
 Table 26. Global Enoxaparin Sodium Price by Sales Channel (US$/Unit) & (2026-2031)
 Table 27. New Sources of Growth in Enoxaparin Sodium Application
 Table 28. Global Enoxaparin Sodium Sales by Company (M Units) & (2020-2025)
 Table 29. Global Enoxaparin Sodium Sales Share by Company (2020-2025)
 Table 30. Global Enoxaparin Sodium Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Enoxaparin Sodium Revenue Share by Company (2020-2025)
 Table 32. Global Enoxaparin Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enoxaparin Sodium as of 2024)
 Table 33. Global Market Enoxaparin Sodium Average Price by Company (US$/Unit) & (2020-2025)
 Table 34. Global Key Manufacturers of Enoxaparin Sodium, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Enoxaparin Sodium, Product Type & Application
 Table 36. Global Key Manufacturers of Enoxaparin Sodium, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 39. North America Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 40. North America Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 42. North America Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 43. North America Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 44. North America Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 45. North America Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 46. Europe Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 47. Europe Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 48. Europe Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 50. Europe Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 51. Europe Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 52. Europe Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 53. Europe Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 54. Southeast Asia Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 55. Southeast Asia Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 56. Southeast Asia Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 57. Southeast Asia Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 58. Southeast Asia Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 59. Southeast Asia Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 60. Southeast Asia Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 61. Southeast Asia Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 62. Israel Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 63. Israel Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 64. Israel Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Israel Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 66. Israel Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 67. Israel Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 68. Israel Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 69. Israel Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 70. China Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 71. China Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 72. China Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 73. China Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 74. China Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 75. China Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 76. China Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 77. China Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 78. India Enoxaparin Sodium Sales by Company (2020-2025) & (M Units)
 Table 79. India Enoxaparin Sodium Sales Market Share by Company (2020-2025)
 Table 80. India Enoxaparin Sodium Revenue by Company (2020-2025) & (US$ Million)
 Table 81. India Enoxaparin Sodium Revenue Market Share by Company (2020-2025)
 Table 82. India Enoxaparin Sodium Sales by Type (2020-2025) & (M Units)
 Table 83. India Enoxaparin Sodium Sales Market Share by Type (2020-2025)
 Table 84. India Enoxaparin Sodium Sales by Sales Channel (2020-2025) & (M Units)
 Table 85. India Enoxaparin Sodium Sales Market Share by Sales Channel (2020-2025)
 Table 86. Sanofi Company Information
 Table 87. Sanofi Description and Business Overview
 Table 88. Sanofi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 89. Sanofi Enoxaparin Sodium Product
 Table 90. Sanofi Recent Development
 Table 91. Techdow (Hepalink) Company Information
 Table 92. Techdow (Hepalink) Description and Business Overview
 Table 93. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 94. Techdow (Hepalink) Enoxaparin Sodium Product
 Table 95. Techdow (Hepalink) Recent Development
 Table 96. Teva Company Information
 Table 97. Teva Description and Business Overview
 Table 98. Teva Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Teva Enoxaparin Sodium Product
 Table 100. Teva Recent Development
 Table 101. Nanjing King-friend Company Information
 Table 102. Nanjing King-friend Description and Business Overview
 Table 103. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Nanjing King-friend Enoxaparin Sodium Product
 Table 105. Nanjing King-friend Recent Development
 Table 106. Rovi Company Information
 Table 107. Rovi Description and Business Overview
 Table 108. Rovi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Rovi Enoxaparin Sodium Product
 Table 110. Rovi Recent Development
 Table 111. Fresenius Kabi Company Information
 Table 112. Fresenius Kabi Description and Business Overview
 Table 113. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Fresenius Kabi Enoxaparin Sodium Product
 Table 115. Fresenius Kabi Recent Development
 Table 116. Fosun Pharma(Gland Pharma) Company Information
 Table 117. Fosun Pharma(Gland Pharma) Description and Business Overview
 Table 118. Fosun Pharma(Gland Pharma) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Fosun Pharma(Gland Pharma) Enoxaparin Sodium Product
 Table 120. Fosun Pharma(Gland Pharma) Recent Development
 Table 121. Amphastar Company Information
 Table 122. Amphastar Description and Business Overview
 Table 123. Amphastar Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Amphastar Enoxaparin Sodium Product
 Table 125. Amphastar Recent Development
 Table 126. Sandoz (Novartis) Company Information
 Table 127. Sandoz (Novartis) Description and Business Overview
 Table 128. Sandoz (Novartis) Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Sandoz (Novartis) Enoxaparin Sodium Product
 Table 130. Sandoz (Novartis) Recent Development
 Table 131. Apotex Company Information
 Table 132. Apotex Description and Business Overview
 Table 133. Apotex Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Apotex Enoxaparin Sodium Product
 Table 135. Apotex Recent Development
 Table 136. Huadong Medicine Company Information
 Table 137. Huadong Medicine Description and Business Overview
 Table 138. Huadong Medicine Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Huadong Medicine Enoxaparin Sodium Product
 Table 140. Huadong Medicine Recent Development
 Table 141. Cipla Company Information
 Table 142. Cipla Description and Business Overview
 Table 143. Cipla Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Cipla Enoxaparin Sodium Product
 Table 145. Cipla Recent Development
 Table 146. Taj Pharma Company Information
 Table 147. Taj Pharma Description and Business Overview
 Table 148. Taj Pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Taj Pharma Enoxaparin Sodium Product
 Table 150. Taj Pharma Recent Development
 Table 151. Chengdu Baiyu Pharmaceutical Company Information
 Table 152. Chengdu Baiyu Pharmaceutical Description and Business Overview
 Table 153. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product
 Table 155. Chengdu Baiyu Pharmaceutical Recent Development
 Table 156. Changzhou Qianhong Bio-pharma Company Information
 Table 157. Changzhou Qianhong Bio-pharma Description and Business Overview
 Table 158. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 159. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product
 Table 160. Changzhou Qianhong Bio-pharma Recent Development
 Table 161. Beijing SL Pharmaceutical Company Information
 Table 162. Beijing SL Pharmaceutical Description and Business Overview
 Table 163. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 164. Beijing SL Pharmaceutical Enoxaparin Sodium Product
 Table 165. Beijing SL Pharmaceutical Recent Development
 Table 166. Production Base and Market Concentration Rate of Raw Material
 Table 167. Key Suppliers of Raw Materials
 Table 168. Enoxaparin Sodium Distributors List
 Table 169. Enoxaparin Sodium Customers List
 Table 170. Enoxaparin Sodium Market Trends
 Table 171. Enoxaparin Sodium Market Drivers
 Table 172. Enoxaparin Sodium Market Challenges
 Table 173. Enoxaparin Sodium Market Restraints
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources


List of Figures
 Figure 1. Enoxaparin Sodium Product Picture
 Figure 2. Global Enoxaparin Sodium Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Enoxaparin Sodium Sales Market Share by Type in 2024 & 2031
 Figure 4. 20 mg/0.2mL Product Picture
 Figure 5. 30 mg/0.3mL Product Picture
 Figure 6. 40 mg/0.4mL Product Picture
 Figure 7. 60 mg/0.6mL Product Picture
 Figure 8. 80 mg/0.8mL Product Picture
 Figure 9. 100 mg/1mL Product Picture
 Figure 10. 120 mg/0.8mL Product Picture
 Figure 11. 150 mg/1mL Product Picture
 Figure 12. 300mg/3mL Product Picture
 Figure 13. Global Enoxaparin Sodium Sales (US$ Million) by Sales Channel (2020 & 2024 & 2031)
 Figure 14. Global Enoxaparin Sodium Sales Market Share by Sales Channel in 2024 & 2031
 Figure 15. Hospital & Clinic Examples
 Figure 16. Pharmacy Examples
 Figure 17. Others Examples
 Figure 18. Global Enoxaparin Sodium Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Enoxaparin Sodium Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 20. Global Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 21. Global Enoxaparin Sodium Price Trends Growth Rate (2020-2031) & (US$/Unit)
 Figure 22. Enoxaparin Sodium Report Years Considered
 Figure 23. Global Market Enoxaparin Sodium Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 24. Global Enoxaparin Sodium Revenue Market Share by Region: 2020 VS 2024
 Figure 25. North America Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 26. North America Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 27. Europe Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 28. Europe Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 29. Southeast Asia Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 30. Southeast Asia Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 31. Israel Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 32. Israel Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 33. China Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 34. China Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 35. India Enoxaparin Sodium Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 36. India Enoxaparin Sodium Sales (M Units) Growth Rate (2020-2031)
 Figure 37. Global Enoxaparin Sodium Revenue Share by Type (2020-2025)
 Figure 38. Global Enoxaparin Sodium Sales Share by Type (2026-2031)
 Figure 39. Global Enoxaparin Sodium Revenue Share by Type (2026-2031)
 Figure 40. Global Enoxaparin Sodium Revenue Share by Sales Channel (2020-2025)
 Figure 41. Global Enoxaparin Sodium Revenue Growth Rate by Sales Channel in 2020 & 2024
 Figure 42. Global Enoxaparin Sodium Sales Share by Sales Channel (2026-2031)
 Figure 43. Global Enoxaparin Sodium Revenue Share by Sales Channel (2026-2031)
 Figure 44. Global Enoxaparin Sodium Sales Share by Company (2024)
 Figure 45. Global Enoxaparin Sodium Revenue Share by Company (2024)
 Figure 46. Global 5 Largest Enoxaparin Sodium Players Market Share by Revenue in Enoxaparin Sodium: 2020 & 2024
 Figure 47. Enoxaparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 48. Manufacturing Cost Structure of Enoxaparin Sodium
 Figure 49. Manufacturing Process Analysis of Enoxaparin Sodium
 Figure 50. Enoxaparin Sodium Industrial Chain
 Figure 51. Channels of Distribution (Direct Vs Distribution)
 Figure 52. Distributors Profiles
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Heparin Sodium Market Insights Forecast to 2030
Sodium Heparin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heparin Sodium Injection Market Insights Forecast to 2030
Global Enoxaparin API Market Research Report 2025
Global Bovine Heparin Sodium Market Research Report 2025
Global Enoxaparin Sodium For Injection Market Research Report 2025
Global Heparin Market Insights Forecast to 2030
Heparin Sodium API and Heparin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heparin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
High Purity Heparin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enoxaparin Sodium Injection Market Research Report 2024
Global Fondaparinux Market Research Report 2024
Global Enoxaparin Sodium APIs and Preparations Market Insights Forecast to 2030
Global Low Molecular Weight Heparin Sodium Market Insights Forecast to 2030
Global Heparin Anticoagulant Market Insights Forecast to 2028
Global Heparin Sodium Tube Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Warfarin Sodium Tablets Market Research Report 2024
Anticoagulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Anticoagulants Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions